Evogene Ltd. (EVGN.TA)
ILA 399.6
(2.72%)
ILA 399.6
(2.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -23.26 Million USD | 4.36% |
| 2022 | -27 Million USD | 10.97% |
| 2021 | -27.88 Million USD | -30.68% |
| 2020 | -23.21 Million USD | -28.61% |
| 2019 | -18.39 Million USD | 3.74% |
| 2018 | -17.96 Million USD | 6.34% |
| 2017 | -18.68 Million USD | 5.29% |
| 2016 | -18.81 Million USD | -21.6% |
| 2015 | -15.48 Million USD | -17.95% |
| 2014 | -13 Million USD | -72.55% |
| 2013 | -6.67 Million USD | -441.03% |
| 2012 | -1.29 Million USD | 74.05% |
| 2011 | -1.76 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3 Million USD | 59.66% |
| 2024 Q2 | -5.24 Million USD | -74.5% |
| 2023 Q4 | -7.45 Million USD | -141.09% |
| 2023 FY | - USD | 4.36% |
| 2023 Q1 | -5.84 Million USD | -96.74% |
| 2023 Q2 | -6.86 Million USD | -17.38% |
| 2023 Q3 | -3.09 Million USD | 54.93% |
| 2022 FY | - USD | 10.97% |
| 2022 Q4 | -2.97 Million USD | 52.51% |
| 2022 Q3 | -6.25 Million USD | 9.96% |
| 2022 Q2 | -6.95 Million USD | 5.22% |
| 2022 Q1 | -7.33 Million USD | -1.82% |
| 2021 Q3 | -7.62 Million USD | -20.94% |
| 2021 FY | - USD | -30.68% |
| 2021 Q1 | -5.64 Million USD | 2.91% |
| 2021 Q2 | -6.3 Million USD | -11.69% |
| 2021 Q4 | -7.2 Million USD | 5.58% |
| 2020 Q2 | -3.99 Million USD | 34.23% |
| 2020 Q3 | -4.62 Million USD | -15.76% |
| 2020 FY | - USD | -28.61% |
| 2020 Q1 | -6.06 Million USD | -2.1% |
| 2020 Q4 | -5.81 Million USD | -25.89% |
| 2019 Q2 | -3.35 Million USD | -18.47% |
| 2019 Q4 | -5.94 Million USD | -70.73% |
| 2019 Q1 | -2.83 Million USD | 37.58% |
| 2019 FY | - USD | 3.74% |
| 2019 Q3 | -3.48 Million USD | -3.76% |
| 2018 FY | - USD | 6.34% |
| 2018 Q4 | -4.53 Million USD | -6.28% |
| 2018 Q3 | -4.26 Million USD | -11.37% |
| 2018 Q2 | -3.83 Million USD | 2.14% |
| 2018 Q1 | -3.91 Million USD | 23.82% |
| 2017 Q2 | -4.13 Million USD | -3.63% |
| 2017 Q3 | -4.4 Million USD | -6.5% |
| 2017 FY | - USD | 5.29% |
| 2017 Q4 | -5.14 Million USD | -16.7% |
| 2017 Q1 | -3.99 Million USD | 33.62% |
| 2016 Q1 | -2.65 Million USD | 45.1% |
| 2016 Q3 | -4.39 Million USD | -14.58% |
| 2016 FY | - USD | -21.6% |
| 2016 Q4 | -6.01 Million USD | -36.87% |
| 2016 Q2 | -3.83 Million USD | -44.23% |
| 2015 FY | - USD | -17.95% |
| 2015 Q4 | -4.84 Million USD | -99.22% |
| 2015 Q1 | -2.52 Million USD | 41.68% |
| 2015 Q2 | -3.69 Million USD | -46.32% |
| 2015 Q3 | -2.43 Million USD | 34.28% |
| 2014 Q1 | -1.45 Million USD | 61.77% |
| 2014 FY | - USD | -72.55% |
| 2014 Q4 | -4.33 Million USD | -39.03% |
| 2014 Q3 | -3.11 Million USD | -25.27% |
| 2014 Q2 | -2.48 Million USD | -70.95% |
| 2013 Q4 | -3.8 Million USD | -115.44% |
| 2013 Q1 | 383 Thousand USD | 130.42% |
| 2013 FY | - USD | -441.03% |
| 2013 Q2 | -749 Thousand USD | -295.56% |
| 2013 Q3 | -1.76 Million USD | -136.05% |
| 2012 Q2 | -546 Thousand USD | 0.0% |
| 2012 Q3 | -299 Thousand USD | 45.24% |
| 2012 Q4 | -1.25 Million USD | -321.07% |
| 2012 FY | - USD | 74.05% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Matricelf Ltd | -11.51 Million ILA | -102.05% |